Adrian Heald

110PUBLICATIONS
49CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Archival, repository and related studiesImmunogenetics (incl. genetic immunology)Predictive and prognostic markersEpigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (110)

|May 21, 2026
A systematic review and meta-analysis of the relative benefit of dual versus single oral hypoglycaemic therapy following diagnosis with type 2 diabetes (T2D).

|Apr 21, 2026
Graves' Disease: Prospective Up to 10-Year Outcome for 100 Consecutive Individuals at a Single Centre.

|Apr 17, 2026
The insulin-like growth factor system and the progression of renal complications of type 2 diabetes.

|Apr 08, 2026
An Evaluation of Longitudinal Thyroid Hormone Levels Over the Years Before and After Patients Started on Levothyroxine.

Michael Stedman, Peter Taylor, Ian Halsall

|Apr 01, 2026
The development of type 2 diabetes amongst sibling pairs in the South-South region of Nigeria: The effect of genetics, environment and lifestyle.

Sunny Chinenye, Ibi Erekosima, Adrian H Heald

|Mar 14, 2026
Developing a Polygenic Risk Score for Weight Gain in People Treated for Psychosis-Application in a Real-World Setting.

Adrian Heald, Yasitha Illangasekera, Camila Marcelino Loureiro

Pageof 19

Frequent Collaborators

17 joint publications

Mike Stedman

17 joint publications

Mark Livingston

14 joint publications

Anthony A Fryer

12 joint publications

Martin Whyte